Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1994 1
1995 1
1999 1
2002 1
2005 1
2006 1
2007 1
2008 1
2011 1
2012 1
2013 2
2014 4
2015 3
2016 3
2017 2
2018 3
2019 1
2020 4
2021 4
2022 3
2023 5
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

42 results

Results by year

Filters applied: . Clear all
The following terms were ignored: %, %, %
The following terms were not found in PubMed: 20KS, 5BAuthor
Page 1
Diagnosis and outcomes of cachexia in Asia: Working Consensus Report from the Asian Working Group for Cachexia.
Arai H, Maeda K, Wakabayashi H, Naito T, Konishi M, Assantachai P, Auyeung WT, Chalermsri C, Chen W, Chew J, Chou MY, Hsu CC, Hum A, Hwang IG, Kaido T, Kang L, Kamaruzzaman SB, Kim M, Lee JSW, Lee WJ, Liang CK, Lim WS, Lim JY, Lim YP, Lo RS, Ong T, Pan WH, Peng LN, Pramyothin P, Razalli NH, Saitoh M, Shahar S, Shi HP, Tung HH, Uezono Y, von Haehling S, Won CW, Woo J, Chen LK. Arai H, et al. J Cachexia Sarcopenia Muscle. 2023 Oct;14(5):1949-1958. doi: 10.1002/jcsm.13323. Epub 2023 Sep 5. J Cachexia Sarcopenia Muscle. 2023. PMID: 37667992 Free PMC article. Review.
Critical clinical outcomes were determined to be mortality, quality of life as assessed by tools such as EQ-5D or the Functional Assessment of Anorexia/Cachexia Therapy, and functional status as measured by the Clinical Frailty Scale or Barthel Index, with significant emph …
Critical clinical outcomes were determined to be mortality, quality of life as assessed by tools such as EQ-5D or the Functional Asse …
Adjuvant radiotherapy versus early salvage radiotherapy following radical prostatectomy (TROG 08.03/ANZUP RAVES): a randomised, controlled, phase 3, non-inferiority trial.
Kneebone A, Fraser-Browne C, Duchesne GM, Fisher R, Frydenberg M, Herschtal A, Williams SG, Brown C, Delprado W, Haworth A, Joseph DJ, Martin JM, Matthews JHL, Millar JL, Sidhom M, Spry N, Tang CI, Turner S, Wiltshire KL, Woo HH, Davis ID, Lim TS, Pearse M. Kneebone A, et al. Lancet Oncol. 2020 Oct;21(10):1331-1340. doi: 10.1016/S1470-2045(20)30456-3. Lancet Oncol. 2020. PMID: 33002437 Clinical Trial.
Psychometric properties of EQ-5D-5L for use in patients with Graves' disease.
Liu X, Chan WW, Tang EH, Suen AH, Fung MM, Woo YC, Liu SY, Lam CL, Luo N, Wong CK, Lang BH. Liu X, et al. Health Qual Life Outcomes. 2023 Aug 15;21(1):90. doi: 10.1186/s12955-023-02177-z. Health Qual Life Outcomes. 2023. PMID: 37580816 Free PMC article.
BACKGROUND: The EQ-5D-5 L is a commonly used generic measure of health. This study aimed to evaluate the psychometric properties of the EQ-5D-5 L in patients with Graves' disease (GD). ...For convergent validity, there was a moderate negative correlation between EQ- …
BACKGROUND: The EQ-5D-5 L is a commonly used generic measure of health. This study aimed to evaluate the psychometric properties of t …
Association Between Body Mass Index and Functional Outcomes in Patients With Intracerebral Hemorrhage.
Becerril-Gaitan A, Ding D, Ironside N, Southerland AM, Worrall BB, Testai FD, Flaherty ML, Elkind MS, Koch S, Sung G, Kittner SJ, Mayson DJ, Gonzales N, McCauley JL, Malkoff M, Hall CE, Frankel MR, James ML, Anderson CD, Aronowski J, Savitz SI, Woo D, Chen CJ; ERICH investigators. Becerril-Gaitan A, et al. Neurology. 2024 Jan 23;102(2):e208014. doi: 10.1212/WNL.0000000000208014. Epub 2023 Dec 21. Neurology. 2024. PMID: 38165334
Compared with patients with BMI <25 kg/m(2), those with BMI 25 kg/m(2) had better 90-day mRS (aOR = 0.80 [CI 0.67-0.95]), EuroQoL Group 5-Dimension (EQ-5D) (abeta = 0.05 [0.01-0.08]), and EQ-5D VAS (abeta = 3.80 [0.80-6.98]) scores. ...
Compared with patients with BMI <25 kg/m(2), those with BMI 25 kg/m(2) had better 90-day mRS (aOR = 0.80 [CI 0.67-0.95]), EuroQoL Group 5 …
Quality of Life After Fractional Flow Reserve-Guided PCI Compared With Coronary Bypass Surgery.
Fearon WF, Zimmermann FM, Ding VY, Zelis JM, Piroth Z, Davidavicius G, Mansour S, Kharbanda R, Östlund-Papadogeorgos N, Oldroyd KG, Wendler O, Reardon MJ, Woo YJ, Yeung AC, Pijls NHJ, De Bruyne B, Desai M, Hlatky MA; FAME 3 Investigators. Fearon WF, et al. Circulation. 2022 May 31;145(22):1655-1662. doi: 10.1161/CIRCULATIONAHA.122.060049. Epub 2022 Apr 2. Circulation. 2022. PMID: 35369704 Free article. Clinical Trial.
The primary objective was to compare EQ-5D summary index at 12 months. Secondary end points included angina grade and work status. ...The trajectory of EQ-5D during the 12 months differed (P<0.001) between PCI and CABG: at 1 month, EQ-5D was 0.063 (95% CI, …
The primary objective was to compare EQ-5D summary index at 12 months. Secondary end points included angina grade and work status. .. …
Novel Benzoxazoles Containing 4-Amino-Butanamide Moiety Inhibited LPS-Induced Inflammation by Modulating IL-6 or IL-1β mRNA Expression.
Yoo J, Park J, Kim D, Huh Y, Park Choo HY, Woo HA. Yoo J, et al. Int J Mol Sci. 2022 May 10;23(10):5331. doi: 10.3390/ijms23105331. Int J Mol Sci. 2022. PMID: 35628136 Free PMC article.
We synthesized 12 novel compounds with 4-amino-N-(4-(benzo[d]oxazol-2-ylamino)phenyl)butanamide moiety and evaluated their biological activities. Among them, 4 compounds (compound 5d, 5c, 5f, 5m and synthetic intermediate 4d) showed potent inhibition activities on IL-1beta …
We synthesized 12 novel compounds with 4-amino-N-(4-(benzo[d]oxazol-2-ylamino)phenyl)butanamide moiety and evaluated their biological activi …
Restarting antiplatelet therapy after spontaneous intracerebral hemorrhage: Functional outcomes.
Chen CJ, Ding D, Buell TJ, Testai FD, Koch S, Woo D, Worrall BB; ERICH Investigators. Chen CJ, et al. Neurology. 2018 Jul 3;91(1):e26-e36. doi: 10.1212/WNL.0000000000005742. Epub 2018 May 30. Neurology. 2018. PMID: 29848784 Free PMC article.
Secondary outcomes were excellent outcome (modified Rankin Scale score 0-1), mortality, Barthel Index, and health status (EuroQol-5 dimensions [EQ-5D] and EQ-5D visual analog scale scores) at 90 days. RESULTS: The APT and no APT cohorts comprised 127 and 732 patient …
Secondary outcomes were excellent outcome (modified Rankin Scale score 0-1), mortality, Barthel Index, and health status (EuroQol-5 dimensio …
Intracranial pressure monitoring in patients with spontaneous intracerebral hemorrhage.
Chen CJ, Ding D, Ironside N, Buell TJ, Southerland AM, Testai FD, Woo D, Worrall BB; ERICH Investigators. Chen CJ, et al. J Neurosurg. 2019 May 31;132(6):1854-1864. doi: 10.3171/2019.3.JNS19545. J Neurosurg. 2019. PMID: 31151113
Secondary outcomes were in-hospital mortality, hyperosmolar therapy use, ICH evacuation, length of hospital stay, and 90-day modified Rankin Scale (mRS) score, excellent outcome (mRS score 0-1), good outcome (mRS score 0-2), Barthel Index, and health-related quality of life (HRQo …
Secondary outcomes were in-hospital mortality, hyperosmolar therapy use, ICH evacuation, length of hospital stay, and 90-day modified Rankin …
42 results